Navigation Links
IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
Date:4/30/2009

New Technology Represents First True Yellow Laser with CW-Pulse(TM) and MicroPulse(TM) Delivery

MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- IRIDEX Corporation, (Nasdaq: IRIX) today announced the commencement of shipments to customers of the IQ 577 laser systems. The IQ 577 is a high-power, true yellow (577 nm wavelength) laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma.

The IQ 577 offers tangible benefits to both patient and physician. Patients benefit from less discomfort. The higher inherent absorption in blood, together with the lower scattering of the 577 nm yellow laser wavelength, compared with 532 nm green laser systems, helps to reduce the therapeutic power requirements and resultant patient discomfort. Physicians benefit from efficiencies due to its easy to understand user interface, wireless foot pedal control with power adjust capability, and audible confirmation of adjustments.

"The 577 nm laser wavelength previously was available to ophthalmologists only in argon-pumped dye laser systems," commented Theodore A. Boutacoff, President and CEO. "These argon-pumped dye laser systems, now obsolete, were popular at one time; however, they were large, had high electrical power demands, required circulating water for cooling, and were expensive to maintain and service. In contrast, we have directed our company's experience and expertise to develop the IQ 577, reintroducing this laser wavelength to clinicians in a modern product utilizing reliable and efficient solid-state laser technology. The integration of MicroPulse technology into the IQ 577 ensures that it will satisfy not only today's clinical requirements, but also those of the future. Also in contrast to the previous dye laser systems, the IQ 577 visualization optics are substantially clearer and provides the ophthalmic laser surgeon with the ability to visually titrate subtle laser doses, which enhances preservation of viable tissue."

What is MicroPulse Technology?

MicroPulse is a tissue sparing technology offering a benefit over standard laser delivery by electronically "chopping" each laser pulse into microsecond bursts. This enhances the physician's control over the energy delivered to tissue, opening the door to new ocular treatment options, with the goal, once again, of achieving a more tissue sparing laser therapy.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results
2. IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
3. IRIDEX Reports Third Quarter 2008 Financial Results
4. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
5. IRIDEX Reports First Quarter 2008 Financial Results
6. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
7. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
8. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
9. IRIDEX Reports Third Quarter Financial Results
10. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
11. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology ... two biometric time and attendance tracking products: the new NCheck Cloud Bio Attendance ... Bio Attendance uses biometric face recognition to enable users to check in and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Self-Funding Success website has recently developed and published an informational resource that ... was created based on common inquiries the site’s team of third party administrator ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... 2017 , ... Public relations pros work hard to earn placements and ... While many results are clear, much of PR is hard to quantify. Goal-setting and ... to measurement, firms should always take an all-inclusive approach that takes both traditional and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... Columbia , March 27, 2017 LightIntegra ... has appointed William "Bill" Dubiel as President and Chief ... also elected to the Board of Directors of LightIntegra. ... the Executive Chairman of LightIntegra. "This ... next President and Chief Executive Officer. We,ve selected a ...
Breaking Medicine Technology: